LENZ Therapeutics (LENZ) Other Non-Current Assets (2020 - 2026)

LENZ Therapeutics (LENZ) has 7 years of Other Non-Current Assets data on file, last reported at $2.5 million in Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $2.5 million, up 75.46% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.5 million (up 75.46% YoY), and the FY2025 annual result was $2.5 million, up 81.76% from the prior year.
• Other Non-Current Assets declined to $2.5 million in Q1 2026 per LENZ's latest filing, from $2.5 million in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $2.7 million in Q4 2023 and troughed at $1716.0 in Q1 2022.
• A 5-year average of $1.4 million and a median of $1.6 million in 2025 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2023 and 2024: Other Non-Current Assets surged 99900.0% in 2023, then slumped 98.76% in 2024.
• A 5-year view of Other Non-Current Assets shows it stood at $1.7 million in 2022, then soared by 58.82% to $2.7 million in 2023, then tumbled by 48.22% to $1.4 million in 2024, then surged by 81.76% to $2.5 million in 2025, then slipped by 3.46% to $2.5 million in 2026.
• Business Quant data shows LENZ's Other Non-Current Assets at $2.5 million in Q1 2026, $2.5 million in Q4 2025, and $1.6 million in Q3 2025.